---

---

tags : Covid    symbols : GSK   

save search

---

GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration of Sotrovimab for the Early Treatment of COVID-19
Published: 2022-01-13 (Crawled : 15:30) - biospace.com/
SNYNF | News | $92.7 600K |

Health Technology

| -11.65% | O: 0.0% H: 0.0% C: 0.0%
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| -10.44% | O: 0.29% H: 0.0% C: 0.0%
XNCR | $18.585 2.06% 260K |

Health Technology

| -50.04% | O: 0.38% H: 1.12% C: -1.31%
VIR | $8.175 0.93% 320K |

Health Technology

| -79.76% | O: 1.05% H: 1.98% C: -6.88%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -9.97% | O: -0.74% H: 0.0% C: 0.0%
covid-19 treatment fda application covid authorization merge emergency use authorization

---

Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatment of COVID-19
Published: 2021-12-17 (Crawled : 13:30) - globenewswire.com
GLAXF | News | $20.305 630 |

Health Technology

| -4.25% | O: 2.36% H: 0.46% C: 0.46%
SNYNF | News | $92.7 600K |

Health Technology

| -3.77% | O: -0.48% H: 0.0% C: 0.0%
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| -6.11% | O: 0.86% H: 0.0% C: 0.0%
XNCR | $18.585 2.06% 260K |

Health Technology

| -50.23% | O: -0.45% H: 0.0% C: 0.0%
VIR | $8.175 0.93% 320K |

Health Technology

| -85.41% | O: -4.59% H: 0.0% C: 0.0%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -6.04% | O: 0.22% H: 0.0% C: 0.0%
covid-19 treatment europe granted covid authorization grant

---

Anxious World Waits As Covid Vaccine Makers Address Omicron Variant
Published: 2021-12-07 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $20.305 630 |

Health Technology

| 0.89% | O: 5.22% H: 0.0% C: -1.25%
JNJ | News | $150.09 0.65% 4.9M |

Health Technology

| -7.07% | O: 2.13% H: 0.0% C: 0.0%
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| -3.06% | O: 0.14% H: 0.0% C: 0.0%
VIR | $8.175 0.93% 320K |

Health Technology

| -80.87% | O: -6.42% H: 8.6% C: 8.45%
SRNE | $0.015 140K |

Health Technology

| -99.8% | O: 6.57% H: 14.77% C: 11.21%
RDHL | $0.4249 -3.96% 410K |

Health Technology

| -83.64% | O: 0.37% H: 10.37% C: 9.63%
covid vaccine

---

CureVac veröffentlicht in „Nature” präklinische Daten des COVID-19-Kandidaten der zweiten Generation, CV2CoV, die vergleichbaren Antikörperspiegel wie bei lizenziertem mRNA-Impfstoff nachweisen
Published: 2021-11-18 (Crawled : 11:00) - curevac.com
GLAXF | News | $20.305 630 |

Health Technology

| -5.27% | O: -6.25% H: 3.09% C: -0.45%
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| -3.93% | O: -1.66% H: 0.24% C: -0.12%
CVAC | $2.55 0.79% 370K |

Health Technology

| -93.16% | O: 8.03% H: 4.75% C: 2.8%
covid cv2cov

---

GSK and Vir Biotechnology Announce United States Government Agreements to Purchase Sotrovimab, a COVID-19 Treatment
Published: 2021-11-17 (Crawled : 12:00) - globenewswire.com
GLAXF | News | $20.305 630 |

Health Technology

| -1.74% | O: 1.43% H: 2.31% C: 2.27%
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| -4.2% | O: -0.28% H: 0.0% C: 0.0%
VIR | $8.175 0.93% 320K |

Health Technology

| -75.19% | O: 9.97% H: 4.0% C: -6.28%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -9.64% | O: -0.06% H: 0.0% C: 0.0%
covid treatment biotech technology iot covid-19

---

Primary endpoint met in COMET-TAIL Phase 3 trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19
Published: 2021-11-12 (Crawled : 13:00) - biospace.com/
GLAXF | News | $20.305 630 |

Health Technology

| -3.17% | O: 1.8% H: 0.0% C: -0.31%
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| -5.78% | O: 0.93% H: 0.0% C: 0.0%
VIR | $8.175 0.93% 320K |

Health Technology

| -75.0% | O: 4.66% H: 0.0% C: 0.0%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -10.09% | O: -0.66% H: 0.0% C: 0.0%
covid treatment phase 3 trial

---

CureVac verlagert Fokus der COVID-19-Impfstoffentwicklung auf mRNA-Technologie der zweiten Generation
Published: 2021-10-12 (Crawled : 12:00) - curevac.com
GLAXF | News | $20.305 630 |

Health Technology

| 4.1% | O: 3.38% H: 0.0% C: -5.75%
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| 6.15% | O: 2.51% H: 0.15% C: -1.43%
CVAC | $2.55 0.79% 370K |

Health Technology

| -94.14% | O: -13.04% H: 13.08% C: 9.7%
covid covid-19

---

Cardiovascular Devices Market Witnesses Neutral Impact with Growth Worth $ 32.06 Billion due to COVID-19 | Technavio
Published: 2021-09-17 (Crawled : 10:00) - prnewswire.com
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| 3.78% | O: -0.41% H: 0.0% C: 0.0%
covid cardiovascular growth device cardio covid-19

---

High Virus Count in the Lungs Drives Covid-19 Deaths
Published: 2021-08-31 (Crawled : 09:00) - prnewswire.com
JNJ | News | $150.09 0.65% 4.9M |

Health Technology

| -14.13% | O: -0.1% H: 0.58% C: -0.21%
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| -0.78% | O: -0.61% H: 0.52% C: 0.2%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -10.49% | O: 0.02% H: 0.4% C: 0.14%
covid lungs covid-19

---

Biologics Global Market Report 2021: COVID-19 Impact and Recovery to 2030
Published: 2021-08-17 (Crawled : 22:00) - prnewswire.com
JNJ | News | $150.09 0.65% 4.9M |

Health Technology

| -16.91% | O: 0.02% H: 0.0% C: -1.29%
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| -4.11% | O: 0.17% H: 0.66% C: -0.59%
covid covid-19

---

Global Anaphylaxis Treatment Market Research Report 2021: Rise in Cases of Allergies Post Administration of COVID-19 Vaccines
Published: 2021-08-10 (Crawled : 18:00) - prnewswire.com
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| 0.02% | O: 0.02% H: 0.38% C: 0.15%
covid treatment vaccine research

---

Drug Delivery Devices Global Markets Report 2021: COVID-19 Impacts, Implications and Growth Factors to 2030
Published: 2021-08-06 (Crawled : 15:00) - prnewswire.com
WST | $388.85 3.65% 290K |

Health Technology

| -11.82% | O: -0.71% H: 1.44% C: 1.15%
NVS | News | $97.25 2.24% 2.6M |

Health Technology

| 2.73% | O: -0.85% H: 0.15% C: -0.16%
JNJ | News | $150.09 0.65% 4.9M |

Health Technology

| -14.15% | O: 0.16% H: 0.0% C: 0.0%
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| -0.81% | O: -0.95% H: 0.23% C: -0.3%
ABT | News | $107.91 0.78% 1.7M |

Health Technology

| -12.39% | O: -0.05% H: 0.0% C: 0.0%
MMM | $93.21 0.64% 2.2M |

Producer Manufacturing

| -53.17% | O: 0.19% H: 0.54% C: -0.03%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -8.48% | O: 0.26% H: 0.0% C: 0.0%
OSUR | News | $5.5 2.8% 280K |

Health Technology

| -55.34% | O: 0.42% H: 0.0% C: -2.24%
PODD | $167.12 1.64% 280K |

Health Technology

| -41.37% | O: 0.91% H: 0.0% C: -2.64%
covid drug growth device drug delivery liver

---

Global Coronavirus (COVID-19) Vaccine Markets, Competition Forecast & Opportunities, 2026 - Moderna, Pfizer, AstraZeneca are Leading the Race and is Currently Administered to Entire Population
Published: 2021-07-30 (Crawled : 18:00) - prnewswire.com
JNJ | News | $150.09 0.65% 4.9M |

Health Technology

| -13.39% | O: 0.15% H: 0.0% C: 0.0%
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| 1.22% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -10.2% | O: 0.76% H: 0.0% C: 0.0%
MRNA | News S | $108.03 3.42% 1.5M |

Health Technology

| -69.78% | O: 0.32% H: 0.0% C: 0.0%
AZN | News | $70.93 1.14% 3.8M |

Health Technology

| 21.67% | O: -0.33% H: 0.0% C: 0.0%
covid vaccine

---

GSK and Vir Biotechnology Announce Joint Procurement Agreement with European Commission for COVID-19 Treatment, Sotrovimab
Published: 2021-07-28 (Crawled : 12:00) - biospace.com/
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| 2.71% | O: -1.06% H: 1.31% C: 1.02%
VIR | $8.175 0.93% 320K |

Health Technology

| -77.77% | O: 1.54% H: 4.68% C: 0.14%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -10.32% | O: -0.5% H: 1.7% C: 1.4%
covid treatment europe biotech technology iot covid-19

---

COVID-19 Welcomes a New Era in Vaccinology. mRNA Based Vaccines to Reach US$127.3 Billion by the Year 2027
Published: 2021-06-29 (Crawled : 13:00) - prnewswire.com
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| 1.78% | O: 0.23% H: 0.33% C: -0.05%
BNTX | News | $88.54 0.6% 220K |

Health Technology

| -61.47% | O: -0.94% H: 2.51% C: 0.78%
covid vaccine

---

North America Preventive Vaccines Market: COVID-19 Impact and Growth Opportunity 2021-2026
Published: 2021-06-11 (Crawled : 20:00) - prnewswire.com
NVAX | $4.245 4.3% 2.3M |

Health Technology

| Email alert Add to watchlist
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| Email alert Add to watchlist
AZN | News | $70.93 1.14% 3.8M |

Health Technology

| Email alert Add to watchlist
JNJ | News | $150.09 0.65% 4.9M |

Health Technology

| Email alert Add to watchlist
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| Email alert Add to watchlist
covid vaccine growth covid-19

---

GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives Emergency Use Authorization from the US FDA for Treatment of Mild-to-Moderate COVID-19 in High-Risk Adults and Pediatric Patients
Published: 2021-05-26 (Crawled : 23:00) - globenewswire.com
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| 4.86% | O: -0.8% H: 0.69% C: 0.23%
LLY | News | $744.47 1.8% 1M |

Health Technology

| 263.86% | O: -0.17% H: 0.36% C: -0.72%
VIR | $8.175 0.93% 320K |

Health Technology

| -82.3% | O: 4.2% H: 0.3% C: -9.4%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -14.16% | O: -0.5% H: 0.32% C: -1.27%
covid treatment fda risk biotech technology iot merge authorized emergency use authorization

---

CORRECTION -- EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For the Early Treatment of COVID-19
Published: 2021-05-21 (Crawled : 14:00) - globenewswire.com
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| 4.0% | O: -0.26% H: 0.26% C: -0.21%
LLY | News | $744.47 1.8% 1M |

Health Technology

| 266.53% | O: 0.24% H: 0.96% C: -0.06%
VIR | $8.175 0.93% 320K |

Health Technology

| -82.06% | O: 1.75% H: 0.13% C: -1.44%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -14.37% | O: -0.43% H: 0.2% C: 0.02%
covid treatment positive biotech technology iot ema

---

EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For the Early Treatment of COVID-19
Published: 2021-05-21 (Crawled : 12:15) - globenewswire.com
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| 4.0% | O: -0.26% H: 0.26% C: -0.21%
LLY | News | $744.47 1.8% 1M |

Health Technology

| 266.53% | O: 0.24% H: 0.96% C: -0.06%
VIR | $8.175 0.93% 320K |

Health Technology

| -82.06% | O: 1.75% H: 0.13% C: -1.44%
SNY | News | $47.72 1.21% 1.1M |

Health Technology

| -14.37% | O: -0.43% H: 0.2% C: 0.02%
covid treatment positive biotech technology iot ema

---

$24.5 Billion Worldwide Sports Drinks Industry to 2027 - Impact of COVID-19 on the Market
Published: 2021-05-18 (Crawled : 21:00) - prnewswire.com
GSK | News | $41.165 1.42% 1.3M |

Health Technology

| 2.6% | O: -0.66% H: 0.35% C: -0.13%
KO 4 | $60.645 0.16% 8.4M |

Consumer Non-Durables

| 11.43% | O: -0.4% H: 0.11% C: 0.09%
covid covid-19

---

Gainers vs Losers

86%

14%

Top 10 Gainers

MTTR | News M | $4.56 162.07% 21M |

AGBA | $2.74 119.2% 52M |

Finance

CZOO | $9.07 81.76% 22M |

EDBL | News | $6.56 74.47% 1.8M |

MTC | $2.21 41.67% 5.6M |

Technology Services

OPRT | News | $3.12 38.67% 11M |

Finance

PALI | $6.59 33.67% 23M |

Manufacturing

VNRX | $0.7989 33.15% 3.2M |

Health Technology

BTCM | $3.51 30.0% 730K |

Arts, Entertainment, and Recrea...

MLEC | $1.81 29.29% 2.8M |

n/a

---

Your saved searches

---